Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.

Literature DB >> 1125562

Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.

Abstract

Widespread application of clobetasol propionate resulted in suppression of the hypothalamic pituitary axis in four patients. Three patients showed Cushigoid features and developed symptoms of adrenocortical insufficiency on withdrawal of clobetasol.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1975 PMID： 1125562 PMCID： PMC1681806 DOI： 10.1136/bmj.2.5968.419

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

8 in total

1. THE ADRENOCORTICAL RESPONSE TO INSULIN-INDUCED HYPOGLYCAEMIA.

Authors: J LANDON; V WYNN; V H JAMES
Journal: J Endocrinol Date: 1963-11 Impact factor: 4.286

2. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases.

Authors: H Baker; T J Ryan
Journal: Br J Dermatol Date: 1968-12 Impact factor: 9.302

3. Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate.

Authors: V H James; D D Munro; M Feiwel
Journal: Lancet Date: 1967-11-18 Impact factor: 79.321

4. Pustular psoriasis with adrenal suppression following topical corticosteroids.

Authors: R S Tan
Journal: Proc R Soc Med Date: 1974-08

5. The effect on plasma corticosteroid levels of the short term topical application of clobetasol propionate.

Authors: S R Walker; L Wilson; L Fry; V H James
Journal: Br J Dermatol Date: 1974-09 Impact factor: 9.302

6. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors: B E Murphy
Journal: J Clin Endocrinol Metab Date: 1967-07 Impact factor: 5.958

7. Adrenal and pituitary functions during long-term topical steroid therapy.

Authors: J C Hendrikse; A J Moolenaar
Journal: Dermatologica Date: 1972

8. Percutaneous absorption of corticosteroids: systemic effects.

Authors: R B Scoggins; B Kliman
Journal: N Engl J Med Date: 1965-10-14 Impact factor: 91.245

8 in total

15 in total

1. Effect on adrenal function of topically applied clobetasol propionate (Dermovate).

Authors: C F Allenby; R A Main; R A Marsden; C G Sparkes
Journal: Br Med J Date: 1975-12-13

2. Cyclone Tracy.

Authors: P Rhodes
Journal: Br Med J Date: 1975-08-16

3. Cardiac rehabilitation 1975. Summary of the Report of a Joint Working Party of the Royal College of Physicians of London and the British Cardiac Society on Rehabilitation after Cardiac Illness.

Authors:
Journal: Br Med J Date: 1975-08-16

Review 4. The role of topical corticosteroids in bullous pemphigoid in the elderly.

Authors: Pascal Joly; Juliette Fontaine; Jean-Claude Roujeau
Journal: Drugs Aging Date: 2005 Impact factor: 3.923

Review 5. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.

Authors: Therdpong Tempark; Voraluk Phatarakijnirund; Susheera Chatproedprai; Suttipong Watcharasindhu; Vichit Supornsilchai; Siriwan Wananukul
Journal: Endocrine Date: 2010-10-23 Impact factor: 3.633

6. Importance of a thorough drug history in presurgical patients.

Authors: Shibby Robati; Mohammad Kamren Shahid; Adrian Vella; Adrien Vella; Simon Rang
Journal: BMJ Case Rep Date: 2014-03-14

7. Adrenal suppression following low-dose topical clobetasol propionate.

Authors: E M Ohman; S Rogers; F O Meenan; T J McKenna
Journal: J R Soc Med Date: 1987-07 Impact factor: 5.344

8. Pituitary-adrenal and pituitary-thyroid function during administration of difluocortolone and dexamethasone to human subjects.

Authors: R F Lambe; D A O'Kelly; A Darragh
Journal: Ir J Med Sci Date: 1978-01 Impact factor: 1.568

Review 9. Clinical use of topical cortisteroids.

Authors: I B Sneddon
Journal: Drugs Date: 1976 Impact factor: 9.546

10. Emotional lability secondary to the application of a very potent topical corticosteroid.

Authors: Srinivasa Sastry Malladi
Journal: Indian J Psychiatry Date: 2009 Jul-Sep Impact factor: 1.759